KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.
Molekulargewicht:
242.24
Reinheit:
0.9989
CAS Nummer:
[1143863-69-7]
Formel:
C15H11FO2
Target-Kategorie:
Others|||HSP
T15646
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten